Lyndra Therapeutics Appoints Adam Sayer as CEO to Drive Innovation in Long-Acting Oral Therapies
Watertown, MA, January 28, 2025 (Business Wire) -- Adam Sayer has been appointed President and CEO of Lyndra Therapeutics, where he will also serve on the Board of Directors. Sayer brings significant healthcare transformation experience from his role at Envision Healthcare. He is set to lead the company’s efforts to bring long-acting oral therapies, including LYN-005, to market.
Read full article here.
Comments